The size of the global market for large volume parenteral (LVP) was estimated at USD 9.5 billion in 2021 and is anticipated to reach USD 15.0 billion in 2030, exhibiting a CAGR of 6.0% during the anticipated timeframe. Worldwide, growing natality rates, preterm birth rates, and malnutrition prevalence are driving market expansion. In addition, rising rates of non-communicable diseases like diabetes, hypertension, obesity, and other metabolic disorders are a result of the world’s rising fast food intake. The adoption of LVPs, which are a combination of dextrose, lipids, amino acids, trace metals, added electrolytes, and vitamins, is being favorably influenced by this.
The market for LVP is expected to be driven by factors such as the rise in local manufacturing, the need for a quicker method of drug administration, the rising preference for single-dose administration of vaccines and medications, and the rising number of surgeries. Another important reason in the high volume parenteral market is the expanding patient population of people with chronic diseases. For instance, Boehringer Ingelheim GmbH reported in August 2021 that heart failure, a chronic, incapacitating cardio-renal-metabolic disease, affects at least 60 million individuals worldwide. Modern therapy alternatives are urgently needed as the prevalence of heart failure continues rising. These patients must require the proper amount of essential nutrients to help them stay hydrated, energetic, and strong. The parenteral route of administration helps deliver an accurate dose of medicine as most of the drug is straight absorbed in circulation, skipping the gastrointestinal tract. Hence, target disease act as a crucial factor to upsurge market growth throughout the forecast period. The global large volume parenteral (LVP) market size was valued at USD 9.5 billion in 2021 and is projected to reach around USD 15.0 billion in 2030 exhibiting a CAGR of 6.0% in the forecasted period. The increasing prevalence of malnutrition, rising natality rate, and increasing premature births worldwide are fuelling the market growth. Apart from this, the increasing consumption of fast food across the world has resulted in growing instances of non-communicable diseases, such as diabetes, hypertension, obesity, and other metabolic disorders. This is positively impelling the adoption of LVPs that are a mixture of dextrose, lipids, amino acids, trace metals, added electrolytes, and vitamins.
Download a Sample Copy of Large Volume Parenteral Market: https://analyticsmarketresearch.com/sample-request/large-volume-parenteral-market/10387/
The forced lockdowns and closures upset markets all over the globe. A shortage of raw materials affected the majority of the healthcare sectors in this situation. Industries were shut down, which disrupted the supply system. However, the creation of monoclonal antibodies and vaccines in injectable form led to a desire for LVP. Anti-SARS-CoV-2 monoclonal antibodies are frequently derived from either the B cells of people who have recovered from COVID-19 or from humanized mice, according to the article “Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis Can’t Come Fast Enough for Some People” that was published in October 2021. On the SARS-CoV-2 spike protein, they target epitopes. No matter the condition of the recipient’s immune system, monoclonal antibodies give almost direct, albeit temporary, “passive immunity” when infused or injected. The benefits of injected monoclonal antibodies as therapeutics in helping Covid-19 are predicted to have a considerable impact on the market. Thus, Covid-19 is predicted to have impacted the market significantly.
Type Insights
In 2021, Soft Bags’ large volume parenteral segment dominated the worldwide large volume parenteral market with a revenue share of more than 40%. The parenteral brands with high volume sales have been given a tremendous chance to grow as a result of the segment’s quick adoption of soft bags.
Cozy purse Large Volume Parenteral (LVP) is an injection fluid contained in a flexible plastic substance. With the help of this device, you can give someone nutrition, hydration, and medication. Additionally, it provides patients who are unable to eat normally, as well as those having surgery or other medical procedures that cause a loss of appetite, with the essential nutrients to avoid malnutrition.
Application Insights
Injections for fluid equilibrium will command the market in 2021. Fluid balance injections employ Large Volume Parenteral (LVP) to increase fluid consumption. LVP facilitates hydration more quickly than consuming fluids alone, which is beneficial for those who may need more liquids due to illness.
Region Insights
North America leads the large volume parenteral market owing to the presence of major key players, high research expenditure by healthcare sector, technological development in medical devices in this region. The comprehensions on the growing prevalence of chronic diseases in the United States is one of the major factors driving the growth of the market. For instance, according to the Cancer Facts & Figures 2022 data issued by the American Cancer Society, there will be projected 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the US. Additionally, in the Heart Disease Facts published by the Center for Disease Control and Prevention (CDC) in February 2022, it is declared that coronary heart disease is the most common type of heart disease in the US and around 18.2 million adults aged 20 and older have this in the country.
However, large volume parenteral market in the Asia-Pacific and Europe is anticipated to grow during the forecast period owing to the increasing research and development activities, rising investment in the healthcare sector, and growing focus of emerging markets.
Key Companies Insights
Key players are aiming on their technological partnerships, collaborations, and merger & acquisitions policies to gain a competitive edge and expand their product portfolio & business footmark. The ongoing COVID-19 pandemic hindered the healthcare systems globally and driven market players to update products for unexploited prospects. Some of the key players operating in the global large volume parenteral market include:
• Albert David Ltd.
• B. Braun Melsungen AG
• Baxter
• BML Parenteral Drugs
• Fresenius Kabi AG
• Grifols, S.A.
• Pfizer, Inc.
• Sichuan Kelun Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical Co., Ltd.
• Cipla Inc.
• Zydus Group
• ALTHEA
• Other players
Some of the Recent Developments:
• In June 2022, Akums Drugs & Pharmaceuticals Ltd. (India) acquired the strict European Union (EU) GMP approval for two of their manufacturing units in Haridwar. One plant manufactures solid oral dosage forms such as hard gelatin capsules, tablets, powders in sachets, etc. belonging to the general category, and another plant manufactures large volume parenteral and small volume parenteral lines, including ampoules, vials, eyedrops, FFS and for dry powder injections in the penicillin line.
• In May 2022, the government of India revised the Drug Rule 1945 and delivered a notification to add a sub-rule under Rule 75 (3). This sub-rule will instruct submitting an application with the licensing expert in Form 27D to grant or renew a license for manufacturing, selling, or distributing medicinal drugs in a large volume of parenteral, sera and vaccine, and r-DNA derived drugs.
Segments
By Type
• Soft Bag LVP
• Plastic Bag LVP
• Glass Bottle LVP
By Volume
• 250 ml – 500 ml
• 100 ml-250 ml
• 500 ml – 1000 ml
• 1000 ml – 2000 ml
• 2000 ml and More
By Application
• Fluid Balance Injections
• Nutritious Injections
• Therapeutic Injections
By End User
• Hospitals
• Clinics
• Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
The Global Large Volume Parenteral Market refers to the worldwide market for medical products that are administered intravenously (through injection into a vein) in large volumes. These products are typically used to deliver nutrients, fluids, electrolytes, or medications directly into the bloodstream. The market for these products includes both brand-name and generic drugs, and it is primarily driven by demand from hospitals, clinics, and other healthcare providers. The market is highly regulated, and products must meet strict quality and safety standards in order to be approved for use. Key players in the global large volume parenteral market include pharmaceutical companies, medical device manufacturers, and healthcare distributors.
Key Questions Answered in the Report:
- What will be the development pace of market? What is the growth rate of the global market?
- Who are the key manufacturers in the market space? Who are the world’s leading manufacturers?
- What are sales, revenue, and price analysis of the top manufacturers of market?
- Who are the distributors, traders, and dealers of market? What are the key factors driving the Global market?
- What are the market opportunities and threats faced by the vendors in the industries?
- What are deals, incomes, and value examinations by types and applications of the market?
- What are the primary factors driving market?
- What are the market’s advantages, disadvantages, and risks, as well as an overview of the market?
- Who are the Top Manufacturers in the Market in Terms of Sales, Revenue, and Price Analysis?
- Analysis of Industry Revenue, Sales, and Pricing, what is the difference between Equipment by region, type, and application?
